Cutting Edge Superconductors is producing MgB2 bulk samples, powders, wires and tapes for the next generation cryogen-free 1.5T MRI based on our patented technology. This next generation MRI is designed to reduce the patient's MRI scan cost by about 40%, significantly enhancing public health services. We are in the process of establishing a manufacturing facility of MgB2 wires in Puerto Rico, which could create high tech jobs for the community.

The primary customer is MRI companies, such as GE HealthCare [GE support letter] and ASG Superconductors, and potential customers including Siemens, Phillips, Toshiba, Hitachi. NMR manufacturing companies, such as Bruker and Jeol, are also potential customers, because NMR has the same helium shortage issues. In particular, Bruker wants to test our long length MgB2 wires for their NMR, in order to replace the current NbTi wires by our MgB2 wires.

The end user (the patients/insurance companies) have the opportunity to see the benefits of lower cost MRI imaging.

DEAL highlights

  1. A global leader in Next Generation Cryogen-free 1.5T MRI
  2. Patented technology registered in 7 countries: US, Germany, Netherlands, Italy, Japan, China, and Korea
  3. Frost and Sullivan North America Innovation Leadership Award for MRI Technology
  4. Experienced management team in Science, Technology, and Industry
  5. Collaborating with major MRI companies and Superconducting wire companies to bring Cryogen-free 1.5T MRI to market

success to date

  • EnterPrize Business Plan competition – 1st Prize by Guayacan Group, $25,000, Dec. 2011.
  • InnoVenture Technology based Business Plan Competition – 2nd Prize by PR SBTDC, $15,000, June 2012.
  • Frost and Sullivan North America Innovation Leadership Award, Dec. 2013
  • NSF SBIR Phase I and Phase IB Awards, $180,000 for manufacturing MgB2 wires for cryogen-free 1.5T MRI in collaboration with LUVATA and GE Global Research, Matching funds from PR Science Trust, $210,000, June 2013 - June 2014.
  • NSF Innovation Corps Award for conductive polymeric material, $50,000, PI: Dr. Yong-Jihn Kim, June, 2016.
  • Small Business Innovation Incentive from Puerto Rico Industrial Development Company (PRIDCO) in collaboration with LUVATA and GE Global Research, $50,000, March, 2019 - March, 2023.
  • Job Creation Incentive and Equipment Purchase Incentive from Puerto Rico Department of Economic Development and Commerce, $80,000, March, 2023.


Liquid helium is a cryogenic liquid for the operation of MRI at 4K. In recent years we have seen the global helium supply crisis impacting the MRI industry [1, 2] and Scientific community [3]. For instance, in October and November 2022, NBC News and Forbes reported that it may lead to a medical crisis, because the future of MRI is uncertain [1, 2]. On June 24, 2022, Harvard Crimson also reported that Harvard Physics labs were forced to shut down equipment and suspend projects due to the Helium shortage [3]. About 30% of Helium is consumed for MRI, whereas about 14% of Helium is consumed for laboratory applications in the US.

An MRI needs about 1,700 liters of liquid Helium to operate at 4K [1]. In the US, over 12,000 MRIs are operating. The price of helium was about $5 per liter a decade ago, however it is over $20 per liter now and fluctuating [4].

We believe Cutting Edge Superconductors (CES) is a leader in helium cryogen-free 1.5T MRI and cryogen-free NMR, based on its patent on MgB2 superconductor technology. Dr. Kim, CEO of CES, identified the superconducting mechanism of MgB2, the most important scientific problem in MgB2 research, by inventing the Testardi correlation technique, spotlighted in a review paper on MgB2 [5] in 2001. Furthermore, he invented the world's best patented technique for producing the highest critical current density of MgB2 wires and founded CES in 2011.


Cutting Edge Superconductors (CES) has an international patent for increasing critical currents of MgB2 wires and tapes, enabling cryogen-free 1.5T MRI and cryogen-free NMR. The patent is registered in 7 countries, such as US (7,791,343), EU (2,173,247, registered in Germany, Netherlands, and Italy), Japan (5,792,462), China (1,258,335), and Korea (10-1092345). This next generation MRI is designed to reduce the patient's MRI scan cost by about 40%, significantly enhancing public health services.

CES manufactures its proprietary MgB2 bulk samples, Fig. 1, and Nickel sheathed MgB2 wires, Fig. 2. Our MgB2 wires show superb critical current behavior compared to other company’s wires, as shown below, Fig. 3.

Fig. 1. CES’s proprietary MgB2 bulk samples
Fig. 2. CES’s Ni sheathed MgB2 wire
Fig. 3. Comparison of critical current densities of MgB2 wires from CES and Hypertech research

business model

CES is planning to supply its proprietary MgB2 material to superconducting wire companies and MRI companies to cover the global MRI market. Each MRI needs 20 km long MgB2 wires and tapes that require 20kg of MgB2 material.

CES plans to charge $100,000 for 20kg MgB2 material. CES is planning to produce tons of its proprietary MgB2 material per year, and is planning to also sell the licensing of its worldwide patented technology, for MgB2 bulk samples, powders, MgB2 wires and tapes, and related apparatus, including magnets, MRI, and NMR. Licensing deals are expected to contribute with an upfront fee and royalties of about 3%-5% of the gross sales.

The MRI market size in 2021 is estimated to be $7.26 Billion and is predicted to reach $12 Billion by 2030 with a CAGR (Compound Annual Growth Rate) of 6.2%.


Since the current market size figure needs subscription, we show the market size estimate up to 2016, $5.4 Billion in Fig. 1. The current shortage of Helium may lead to a medical crisis [1]. NMR (Nuclear Magnetic Resonance) can be regarded as a small scale MRI for materials study. It has a market size of $0.86 Billion in 2020 [2].

Fig. 1. MRI Market size


Yong-Jihn Kim, Ph. D.
President and CEO
Proven record of excellence in superconductivity. He identified the superconducting mechanism in MgB2, the most important scientific problem in MgB2 research. He also invented a patented technique to produce the highest critical current densities of MgB2 for next generation cryogen-free 1.5T MRI. Based on this technique, he founded Cutting Edge Superconductors (CES), Inc. on November 22, 2011, in Mayaguez, Puerto Rico.

Hem Kanithi, Ph. D.
Senior Technical Advisor
Former Business Development VP and Head of R&D at LUVATA, no.1 manufacturer of superconducting wires for MRI. He developed process technology for NbTi to exhibit some of the highest critical current densities available today while attaining long piece lengths on an industrial scale. As a result, LUVATA currently supplies NbTi products to produce over 1/3 of global MRI scanners.
Juan Gozalez, MBA
Managing Director
He has a BA in Economics and MBA. More than thirty years of experience working for well-known global financial companies (Citibank, Santander Bank, UBS Wealth Management Americas, Oriental Financial Group).

Use of Proceeds

If the offering's maximum amount of $1,000,000 is raised:

UseValue% of Proceeds
Metal Powders$75,0007.5%
Patent Expense$25,0002.5%
Manufacturing MgB2 Wire$250,00025.0%
Testing MgB2 Wire$100,00010.0%
General & Administrative & Payroll$256,00025.6%
Rent and Utilities$50,0005.0%
Intermediary fees$49,0004.9%


This is an offering of Common Stock, under registration exemption 4(a)(6), in Cutting Edge Superconductors, Inc. . This offering must raise at least $10,000 by August 30, 2023 at 11:59pm ET. If this offering doesn’t reach its target, then your money will be refunded. Cutting Edge Superconductors, Inc. may issue additional securities to raise up to $1,000,000, the offering’s maximum.

If the offering is successful at raising the maximum amount, then the company’s implied valuation after the offering (sometimes called its post-money valuation) will be:

$0.07 per share
$9,750,000implied valuation


These financial statements have been reviewed by an independent Certified Public Accountant.

SEC Filings

The Offering Statement is a formal description of the company and this transaction. It’s filed with the SEC to comply with the requirements of exemption 4(a)(6) of the Securities Act of 1933.

We’re also required to share links to each of the SEC filings related to this offering with investors.

Understand the Risks

Be sure to understand the risks of this type of investment. No regulatory body (not the SEC, not any state regulator) has passed upon the merits of or given its approval to the securities, the terms of the offering, or the accuracy or completeness of any offering materials or information posted herein. That’s typical for Regulation CF offerings like this one.

Neither Netcapital nor any of its directors, officers, employees, representatives, affiliates, or agents shall have any liability whatsoever arising from any error or incompleteness of fact or opinion in, or lack of care in the preparation or publication of, the materials and communication herein or the terms or valuation of any securities offering.

The information contained herein includes forward-looking statements. These statements relate to future events or to future financial performance, and involve known and unknown risks, uncertainties, and other factors, that may cause actual results to be materially different from any future results, levels of activity, performance, or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties, and other factors, which are, in some cases, beyond the company’s control and which could, and likely will, materially affect actual results, levels of activity, performance, or achievements. Any forward-looking statement reflects the current views with respect to future events and is subject to these and other risks, uncertainties, and assumptions relating to operations, results of operations, growth strategy, and liquidity. No obligation exists to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

More Info


  • Aug 31, 2023
    Primary offering finalized, selling 275,543 shares
    Sold 275,543 shares at $0.07 for a total of $19,288.01
  • Aug 30, 2023
    Dear shareholders, We appreciate your support...

    Dear shareholders,

    We appreciate your support by participating in our crowdfunding campaign on Netcapital.

    Currently we are restructuring our company by recruiting several professionals. In addition, we are working hard testing our proprietary MgB2 wire technology with our business partners, to prove its effectiveness and superiority in the superconductor market.

    We want to pause our equity crowdfunding campaign for a few months. We will announce when we resume the equity crowdfunding campaign.

    Once again, thank you for your support and stay tuned.

    If you have any questions, you can contact me through LinkedIn,, or send me an email at

    Read more
  • Aug 24, 2023
  • Aug 22, 2023
    LK-99, the 1st sample, test results: electrical...

    LK-99, the 1st sample, test results: electrical resistivity ~ 1.77X10^-1 ohm cm, and ferromagnetic. The 2nd sample will be made during this week to reduce the resistivity and induce the diamagnetic behavior. Resistance = 2.65 ohm. Stay tuned. #lk99

    Read more
  • Aug 18, 2023
    Cutting Edge Superconductors is ready to...

    Cutting Edge Superconductors is ready to produce lk-99, modified Lead-Apatite. The first sample will be available early next week. We will figure out whether it is a Room Temperature Superconductor or not. Stay tuned. #LK99

    Read more
  • Aug 17, 2023
    Recently we have got $100,000 for equipment...

    Recently we have got $100,000 for equipment purchases from Puerto Rico Department of Economic Development and Commerce (DDEC) and Department of Housing. We will order the necessary equipment to produce our proprietary MgB2 wire soon. Our manufacturing facility can be fully up until the end of this year, and we can produce our proprietary MgB2 wires and tapes early next year.

    Read more
  • Aug 16, 2023
    Leadforce just engaged in our equity...

    Leadforce just engaged in our equity crowdfunding campaign. I hope we can get more investors.

    Read more
  • Aug 9, 2023
    Cutting Edge Superconductors will make LK-99 by...

    Cutting Edge Superconductors will make LK-99 by pellet technique and powder-in-tube (PIT) technique during August. We will measure electrical resistance and check quantum locking to figure out whether LK-99 is a room temperature superconductor or not. Stay tuned!

    read more
  • Aug 6, 2023
    Room temperature...

    Room temperature superconductors?

    Dr. Yong-Jihn Kim has an idea to make a possible room temperature superconductor, improving high Tc cuprates. Invest in Cutting Edge Superconductors, a global leader in superconductor technology.

    Read more
  • Jul 19, 2023
    Helium-free MRI is possible, Facebook...

    Helium-free MRI is possible, Facebook ad,

    Watch now
  • Jul 14, 2023
    Exit Strategy, Our exit strategies are the...

    Exit Strategy,

    Our exit strategies are the following.

    1. IPO (Initial Public Offering) through NASDAQ

    2. Strategic Acquisition or Merger with a major MRI company or a major Superconducting wire company

  • Jul 13, 2023
    Business model, Our business model consists of...

    Business model,

    Our business model consists of selling licenses for cryogen-free 1.5T MRI based on our proprietary MgB2 wires. Non-exclusive licensing is preferred for our business model; however, we could consider an exclusive licensing deal.

    Licensing our proprietary technology will provide us with the cash flow needed to achieve our goal of establishing a manufacturing facility to produce MgB2 wires in Puerto Rico. When the facility is completed, we will produce and sell our proprietary MgB2 wires for cryogen-free 1.5T MRI and cryogen-free NMR directly to prospective clients.

  • Jul 12, 2023
    Dividend Policy The longest-established...

    Dividend Policy

    The longest-established companies where they have reached their growth cap are the ones that typically tend to pay dividends. Companies that are in a growth stage, like ours, generally reinvest any excess capital in their operations in order to reach their optimal production level.

    When our company has enough profits, dividends can be paid out to shareholders.

  • Jul 6, 2023
    Cutting Edge Plastics is a separate company in...

    Cutting Edge Plastics is a separate company in collaboration with Cutting Edge Superconductors (CES), fully owned by our founder Dr. Yong-Jinh Kim. Any merger or acquisition by CES in the future will be properly announced to our shareholders by press release or in our quarterly report, as soon as we start the process.

    For now, we are focusing on our crowdfunding campaign for Cutting Edge Superconductor and our enhanced MgB2 products.

    Thank You

    Read more
  • Jun 30, 2023
    Primary offering of 14,285,715 shares at $0.07
  • Jun 30, 2023

Ask a Question

Proofread your comment before submitting: once it's posted, you can’t edit or delete it. For the fastest help with the web site, email instead of commenting.

Looking to raise capital?
We can help turn your friends, family and customers into investors.

Learn more

Interested in more investment opportunities?
Browse all offerings currently available.

See more